{"name":"Nalu Medical, Inc.","slug":"nalu","ticker":"Private","exchange":"Private","domain":"nalumed.com","description":"Nalu Medical, Inc. is a private MedTech company focused on neuromodulation therapies. The company is developing innovative solutions for various neurological disorders. With a strong pipeline and growing market presence, Nalu Medical is poised to make a significant impact in the industry.","hq":"Carlsbad, CA","founded":0,"employees":"","ceo":"Peter Crosby","sector":"MedTech / Neuromodulation","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Private (~$300M last valuation)","metrics":{"revenue":20000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-14","type":"deal","headline":"Nalu Medical Raises $45M in Series C Funding","summary":"Nalu Medical, Inc. announced the completion of a $45 million Series C funding round, led by new investor, 5AM Ventures.","drugName":"","sentiment":"positive"},{"date":"2023-11-01","type":"regulatory","headline":"Nalu Medical Receives FDA Breakthrough Device Designation for Its Neuromodulation Therapy","summary":"Nalu Medical, Inc. announced that its neuromodulation therapy has received FDA Breakthrough Device Designation, accelerating its development and commercialization.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQTzY1UHNsbGNQYUdTQjRCWG9XenhLWU43NTl0VGxJbnYtSkhKRzFEcVhsUVpaRWdtQzEyRUdfcUFZSDY1b3ZBVE5xckpsTG1rTDFGekN4MWgxRWxWWnNyUk11N3NWcmQ0TUltSUpob05TZGotMkxrVmhKYVpBeGxSb3lVVFRFQlM4RHRPd0Znbw?oc=5","date":"2026-04-01","type":"deal","source":"Modern Healthcare","summary":"Deals tracker: Boston Scientific acquires Valencia Technologies - Modern Healthcare","headline":"Deals tracker: Boston Scientific acquires Valencia Technologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxObzR0S2sydG12NmdxQU5HcVExNlNLOTJOdzZZUEdabWxTb3dHLTRPZ2YzY3F4b0lzMGZvVHA0V0tuczA0STZhSEg5ekM2dXlzRS1QRWh2MS1ha1Boa3lyd0htRHFkaVdNS01XdlZwVmwwMkVXcVphTVZwcjctRVF1aXdWejVDQTNuYUFkTXBjTHpUdXhmTEVF?oc=5","date":"2025-10-22","type":"earnings","source":"Fierce Biotech","summary":"Acquisitive Boston Scientific sees growth rate ease in Q3 - Fierce Biotech","headline":"Acquisitive Boston Scientific sees growth rate ease in Q3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxObjBFQUFtZlZ2S3hFRnA1MktUSnZleTRIeXBMR3h4RWxPQWRoTFE3cW1uYlN0RlhIX1NxU05YNzdjb1N2R2lSb3RpZzkteWEyaWtiUHUtTjl3dElpU3lBZ0R3anhyV1BhLTFyV2d0S0N0VS1SYndHbGxkNHZmbzJ5cHRvMklkUFNjbUV2eU9pb0w4UnZVb3YzWFJabE9ocFlBN0sxeEE5ZF9SVWdYdkE?oc=5","date":"2025-10-20","type":"deal","source":"Fierce Biotech","summary":"Boston Scientific to drop $533M to acquire neurostimulator maker Nalu Medical - Fierce Biotech","headline":"Boston Scientific to drop $533M to acquire neurostimulator maker Nalu Medical","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Boston Scientific","Medtronic","Abbott Laboratories"],"therapeuticFocus":["Neuromodulation","Neurological Disorders"],"financials":null,"yahoo":null}